NeuroRx, Inc.

ACTIVE

1201 N Market St Ste 111, Wilmington, Delaware, United Stateswww.neurorxpharma.comPublic11–50 employeesEstablished: 2015-01-01

Clinical Trials

4 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2015

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

66.7%

Phase 3

22.2%

Trial Status Distribution

Active, not recruiting

22.2%

Available

11.1%

Completed

33.3%

Not yet recruiting

22.2%

Withdrawn

11.1%

Clinical Trials

Trials sponsored by this organization (9)

A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial

Phase 2

Not yet recruiting

interventional

Sep 2026400 participants

NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis

Phase 2

Not yet recruiting

interventional

Mar 202413 participants

NRX-101 for Bipolar Depression With Subacute Suicidal Ideation

Phase 2

Completed

interventional

May 202274 participants

Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.

NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation

Phase 3

Active, not recruiting

interventional

Dec 201972 participants

NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression

Phase 3

Active, not recruiting

interventional

Jun 2019150 participants

NRX101 Glx Biomarker Validation Study

Phase 2

Completed

interventional

Nov 20188 participants

Sequential Therapy for the Treatment of Severe Bipolar Depression.

Phase 2

Completed

interventional

Jan 201822 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations